May 21, 2018 – Curant Health COO, Marc O'Connor, in PharmExec.com: A mad dash to consolidation is sweeping the healthcare industry. It appears that all stakeholders are bulking up and that vertical integration is the new key to long-term viability. Questions about the future direction of Amazon, JPMorgan, Berkshire Hathaway, Walmart, and Humana—along with their […]
April 25, 2018 (Atlanta, GA) - “For the first time I am now positive about my future living with HIV.” – Chattanooga CARES patient Charlie An estimated $300 billion is wasted in U.S. healthcare spending every year due to medication non-adherence. Studies also verify 30 percent of prescriptions never get filled and 50 percent of […]
April 27, 2018 – Curant Health COO, Marc O'Connor, in PharmExec.com: This year’s IDN Biopharma Strategy Summit from CBI was a useful, intimate gathering of roughly 100 industry leaders, approximately 25% of which represented IDNs, 70% pharmaceutical manufacturers, and 5% various service providers. Confirmed: it's tough going for IDNs that want to set up their […]
April 10, 2018 – Curant Health Senior Director of Commercial Strategy & Performance, Jake Caines, in PharmExec.com. If persistence is the gold standard by which brand teams measure success investing the right amount of time in the right type of resources is critical. In part 4 of this 4-part series, we will discuss tactics brand teams […]
Curant Health Director of Clinical Services Vickie Andros shares her HIV therapy insights with Managed Healthcare Executive Advancements in HIV treatment over the past 20 years or so have been absolutely remarkable. When demonstrating excellent adherence to medication therapy, people living with HIV are managing it like a common, chronic condition experiencing increasing longevity […]
[et_pb_section fb_built="1" _builder_version="3.22"][et_pb_row _builder_version="3.25" background_size="initial" background_position="top_left" background_repeat="repeat"][et_pb_column type="4_4" _builder_version="3.25" custom_padding="|||" custom_padding__hover="|||"][et_pb_text _builder_version="4.4.1" background_size="initial" background_position="top_left" background_repeat="repeat" hover_enabled="0"] Physician time constraints, competing priorities for patients and shortcomings in follow-up initiatives are a few of the top causes of medication non-adherence; a $300 billion source of wasted U.S. healthcare spending every year. What can pharma brand teams do […]
Executives from patient care, diagnostics, payer and pharma companies converge to share the inside scoop on outcomes-based contracting Curant Health's COO, Marc O'Connor, recently participated on a panel held at the CBI Outcomes-Based Contracting conference in Philadelphia. Marc was joined on the panel by speakers Harry Vargo of Aetna and Sachin Kamal-Bahl of Pfizer, along […]
Curant Health has partnered with Chattanooga Cares to offer a highly coordinated program of clinical services, reporting, and analytics.
This year’s 340B Winter Conference was bursting at the seams with attendees. There were over 1,630 registrants for the conference representing a 12% growth over last year’s numbers. It was standing room only in the “340B Lessons from the Field” sessions led by many of our covered entity partners. In fact, there is so much […]
Once a prescription is written - just one part of the brand adoption challenge - pharmaceutical manufacturers are limited in their ability to influence patient compliance and persistence. For years, pharma manufacturers have struggled to influence change in the 20-30 percent of prescriptions that never get filled and the estimated 50 percent of patients who […]
